Adherium Smartinhaler Technology in Multinational Study
Filed with ASX · · 3 pages · English
digital health technologies which address sub optimal medication use in chronic disease. RE: ADHERIUM SMARTINHALER TECHNOLOGY IN NEW MAJOR MULTINATIONAL CLINICAL STUDY Directors Dr J Doug Wilson (Chair) Mr Garth Sutherland (Group CEO) Please see attached announcement outlining a new agreement for the supply of Prof. John Mills Mr Jeremy Curnock Cook 5,700 Adherium Smartinhaler™devices plus associa
Earlier from Adherium
Later from Adherium
- Appendix 4D and Interim Consolidated Financial Report
- Clearance to Market in Canada for Flagship Products
- Adherium Smartinhaler in AstraZeneca COPD Study
- Adherium Executes Placement to Fidelity International
- Adherium and AstraZeneca Australia Commercial Pilot Program
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium